Century Therapeutics, Inc. (IPSC) has a market capitalization of $205.17M and trades at $2.37. The 52-week range is 0.342-3.04.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -21.5, Earnings Per Share (EPS) of $-0.11, annual revenue of $109.16M.
The stock has a beta of 1.67, operates in the Healthcare sector.
